Back to Archived News
NIMS Receives Japanese Patent for Its Exer-Rest Platform
Thursday, November 19, 2009
Miami, FL -- Non-Invasive Monitoring Systems, Inc. [NIMS] (OTCBB: NIMU) announced that the Nogawa Patent Office in Japan issued Patent number 4391595 to NIMS on October 16, 2009. This patent, entitled "Reciprocating Movement Platform for Shifting Subject To and Fro In Headwards-Footwards Direction," relates to the comprehensively researched technology underlying NIMS’ Exer-Rest acceleration therapeutic platform. This patent expires on March 18, 2018.
Dr. Marvin A. Sackner, NIMS’ Founder and CEO noted that, "this Japanese Patent is a counterpart to US Patent 6,155,976, first issued for this technology in the year 2000. We are excited about completing this first step towards entering Japan and we are currently evaluating a number of options to commence our Japanese marketing, sales and distribution activities."
Steven Mrha, COO added that, "NIMS’ high quality, commercial strength and multipurpose Exer-Rest is suitable for both rehabilitation facility and home use. For individuals that find it difficult to exercise or have become sedentary, having a means to stay active is extremely important in reducing secondary risks associated with lack of mobility. The Exer-Rest is a wonderful solution and can be used by individuals of all capabilities."
Exer-Rest is currently being marketed and sold in the United States, Canada and other major international markets. It has been cleared by the FDA as an aid to temporarily increase local circulation, to provide temporary relief of minor aches and pains, to reduce morning stiffness and to provide local muscle relaxation. The Exer-Rest is also approved in Europe as an aid for increasing joint mobility. NIMS is currently seeking similar regulatory clearance to market the Exer-Rest in Japan.
This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA). Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those described in our filings with the Securities and Exchange Commission, as well as risks and uncertainties associated with obtaining regulatory approval in Japan, establishing Japanese marketing, sales and distribution activities, the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, technological changes, and other uncertainties. We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA.
Back to Archived News